BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 8, 2006
View Archived Issues
NicOx Shares Soar On Pfizer Deal For Ophthalmic Drugs
The French firm NicOx SA stands to break the bank, to the tune of up to nearly $400 million, per terms of a technology deal with Pfizer Inc. (BioWorld International)
Read More
Basilea Shares Hit Peak On Positive Ceftobiprole Data
Read More
Antisense RNA Therapy Shows Promise In Muscular Dystrophy
Read More
GTC Biotherapeutics’ ATryn Gets Negative Vote In Europe
Read More
Positive Results For ATL-104 Have Alizyme Thinking Ahead
Read More
Diabetica To Receive Up To $41M Through Amylin Deal
Read More
Other News To Note
Read More